{
  "context": {
    "rules": [
      "Rule1: Either Drug X is approved by the FDA or a synthetic alternative for Chemical Y is available at Lab V.",
      "Rule2: In the event that Batch 123 of Drug X is released, then either an alternative supplier for Chemical Y, Supplier V, is found, or, given that it is not the case that there is a raw material shortage of Chemical Y from Supplier Z or a synthetic alternative for Chemical Y is available at Lab V, production is not halted at Factory W.",
      "Rule3: Whenever an order of Drug X is shipped to Distributor U, Batch 123 of Drug X is released.",
      "Rule4: Under the condition that packaging for Drug X is ready at the pack station, then if Drug X passed quality testing at Lab T, an order of Drug X is shipped to Distributor U.",
      "Rule5: Packaging for Drug X is ready at the pack station or labeling for Drug X is complete at the label machine.",
      "Rule6: Provided that labeling for Drug X is complete at the label machine, then if Drug X passed quality testing at Lab T, an order of Drug X is shipped to Distributor U.",
      "Rule7: Under the condition that Drug X is under regulatory review by Agency P, documentation for Drug X is submitted to Agency P.",
      "Rule8: If Drug X is banned in Country Alpha, then Drug X is recalled from the market.",
      "Rule9: Either Drug X is banned in Country Alpha or Drug X is banned in Country Beta.",
      "Rule10: In the event that additional testing for Drug X is required at Lab Q, a Phase III clinical trial is required for Drug X.",
      "Rule11: Whenever documentation for Drug X is submitted to Agency P, additional testing for Drug X is required at Lab Q.",
      "Rule12: Given that Drug X passes an audit by Inspector R, then if Drug X passed quality testing at Lab T, then either an alternative supplier for Chemical Y, Supplier V, is found, or, under the condition that it is not the case that there is a raw material shortage of Chemical Y from Supplier Z or a synthetic alternative for Chemical Y is available at Lab V, production is not halted at Factory W.",
      "Rule13: If Drug X has a compliance certificate for Standard S, then Drug X does not fail an audit by Inspector R.",
      "Rule14: Provided that a backup supplier for Chemical Y, Supplier B, is available, then there is a raw material shortage of Chemical Y from Supplier Z or a synthetic alternative for Chemical Y is available at Lab V.",
      "Rule15: In the event that shipment of Chemical Y is expedited by Supplier C, then there is a raw material shortage of Chemical Y from Supplier Z or a synthetic alternative for Chemical Y is available at Lab V.",
      "Rule16: Ms. Johnson is the logistics coordinator for Chemical Y or Ms. Smith is the procurement manager for Chemical Y.",
      "Rule17: Provided that Ms. Smith is the procurement manager for Chemical Y, shipment of Chemical Y is expedited by Supplier C.",
      "Rule18: Whenever payment for Chemical Y is authorized by the Finance Department, then if Ms. Johnson is the logistics coordinator for Chemical Y, a backup supplier for Chemical Y, Supplier B, is available.",
      "Rule19: If Drug X is banned in Country Beta, then Drug X is not approved by the FDA.",
      "Rule20: Given that there is warehouse space for Chemical Y at Facility N, delivery of Chemical Y is scheduled for Date M.",
      "Rule21: Storage is available for Chemical Y in Warehouse O or, if it is not the case that whenever budget for Chemical Y is not approved by Director K or payment for Chemical Y is not authorized by the Finance Department, a purchase order for Chemical Y is issued to Supplier D, then there is warehouse space for Chemical Y at Facility N.",
      "Rule22: If Container P provides temperature control for Drug X, then Container P has a humidity monitor for Drug X.",
      "Rule23: In the event that Sensor Q is calibrated for Container P, then if Container P has a humidity monitor for Drug X, then if Drug X passed quality testing at Lab T, an order of Drug X is shipped to Distributor U.",
      "Rule24: Whenever maintenance is performed on Sensor R for Container P, then if Container P has a humidity monitor for Drug X, then if Drug X passed quality testing at Lab T, an order of Drug X is shipped to Distributor U.",
      "Rule25: Under the condition that Container P is inspected by Technician S for quality assurance, a validation report for Container P is issued to the Quality Department.",
      "Rule26: Container P is inspected by Technician S for quality assurance or Container P is approved by Supervisor T for quality assurance.",
      "Rule27: Provided that Container P is approved by Supervisor T for quality assurance, then Sensor Q is calibrated for Container P or maintenance is performed on Sensor R for Container P.",
      "Rule28: Whenever a stability test is performed on Container P for Drug X, then Sensor Q is calibrated for Container P or maintenance is performed on Sensor R for Container P.",
      "Rule29: Under the condition that a validation report for Container P is issued to the Quality Department, a stability test is performed on Container P for Drug X.",
      "Rule30: If Drug X is withdrawn by the manufacturer, then Drug X is not approved by the FDA.",
      "Rule31: Given that the FDA changed regulation for Drug X, then if Drug X is recalled from the market, Drug X is withdrawn by the manufacturer.",
      "Rule32: Either the FDA changed regulation for Drug X or the EMA changed regulation for Drug X.",
      "Rule33: Provided that the EMA changed regulation for Drug X, then if Drug X is recalled from the market, Drug X is withdrawn by the manufacturer.",
      "Rule34: If it is not the case that either an alternative supplier for Chemical Y, Supplier V, is found or, under the condition that it is not the case that there is a raw material shortage of Chemical Y from Supplier Z or a synthetic alternative for Chemical Y is available at Lab V, production is not halted at Factory W, then there is a production delay at Factory W.",
      "Rule35: Under the condition that it is not the case that whenever there is a safety issue with Drug X due to side effects, it is not the case that there is a production delay at Factory W, Drug X is under regulatory review by Agency P.",
      "Rule36: Provided that it is not the case that if there is a safety issue with Drug X due to side effects, then it is not the case that there is a production delay at Factory W, it is not the case that a Phase III clinical trial is required for Drug X.",
      "Rule37: In the event that it is not the case that budget for Chemical Y is approved by Director K or payment for Chemical Y is authorized by the Finance Department, then it is not the case that a purchase order for Chemical Y is issued to Supplier D.",
      "Rule38: Provided that it is not the case that there is a raw material shortage of Chemical Y from Supplier Z or a synthetic alternative for Chemical Y is available at Lab V, production is halted at Factory W.",
      "Rule39: In the event that it is not the case that if it is not the case that budget for Chemical Y is approved by Director K or payment for Chemical Y is authorized by the Finance Department, then a purchase order for Chemical Y is issued to Supplier D, then it is not the case that delivery of Chemical Y is scheduled for Date M.",
      "Rule40: Provided that Drug X does not pass an audit by Inspector R, Drug X fails an audit by Inspector R."
    ],
    "facts": [
      "Fact1: Drug X passed quality testing at Lab T.",
      "Fact2: There is a safety issue with Drug X due to side effects.",
      "Fact3: Drug X has a compliance certificate for Standard S.",
      "Fact4: Container P provides temperature control for Drug X.",
      "Fact5: It is not the case that an alternative supplier for Chemical Y, Supplier V, is found.",
      "Fact6: Budget for Chemical Y is not approved by Director K.",
      "Fact7: Storage is not available for Chemical Y in Warehouse O.",
      "Fact8: It is not the case that there is a raw material shortage of Chemical Y from Supplier Z."
    ]
  },
  "question": "A synthetic alternative for Chemical Y is available at Lab V."
}